Literature DB >> 14346780

METHYLDOPA AND AMITRIPTYLINE.

A G WHITE.   

Abstract

Entities:  

Keywords:  AMITRIPTYLINE; DEPRESSION; DRUG SYNERGISM; DRUG THERAPY; HYPERTENSION; METHYLDOPA; TOXICOLOGIC REPORT; TREMOR

Mesh:

Substances:

Year:  1965        PMID: 14346780     DOI: 10.1016/s0140-6736(65)90792-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Studies on the hypotensive action of alpha-methyldopamine.

Authors:  L Finch; A Hersom; P Hicks
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

2.  Antidepressants and heart disease.

Authors:  M L Orme
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-07

3.  The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.

Authors:  J L Reid; A J Porsius; C Zamboulis; G Polak; C A Hamilton; C R Dean
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

4.  Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.

Authors:  H L Elliott; B Whiting; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

6.  Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.

Authors:  C D Burgess; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

7.  Pharmacodynamic studies on mianserin and its interaction with clonidine.

Authors:  H L Elliott; K McLean; D J Sumner; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.